Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stent

@article{Planer2011ComparisonOE,
  title={Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stent},
  author={David Planer and P. C. Smits and Dean J Kereiakes and Elvin Kedhi and Martin Fahy and Ke Xu and Patrick Washington Serruys and Gregg Whitney Stone},
  journal={JACC. Cardiovascular interventions},
  year={2011},
  volume={4 10},
  pages={1104-15}
}
OBJECTIVES This study sought to compare the clinical outcomes of everolimus-eluting stents (EES) versus paclitaxel-eluting stents (PES) in patients with acute coronary syndromes (ACS) and stable coronary artery disease (CAD). BACKGROUND Although randomized trials have shown superiority of EES to PES, the safety and efficacy of EES in ACS is unknown. METHODS We performed a patient-level pooled analysis from the prospective, randomized SPIRIT (Clinical Evaluation of the XIENCE V Everolimus… CONTINUE READING